Mind Cure Health Inc. (MCUR.CN) Research

Mind Cure Health Inc. operates as a life sciences firm, dedicated to creating and marketing mental health and wellness solutions across North America. The company's strategy revolves around advancing digital therapeutic technologies and exploring psychedelic compounds, with the goal of rapidly expanding access to scientifically validated, evidence-based mental health treatments. Among its key innovations is iSTRYM, a unique digital therapeutic software application designed to enhance the entire healing journey for patients and clinicians throughout all phases of therapy. It also offers PsyCollage, a bioinformatics platform crucial for guiding research by identifying priority programs. Furthermore, Mind Cure Health produces synthetic ibogaine for distribution to researchers and clinicians, and investigates various psychedelic compounds, particularly ibogaine, for its potential in treating traumatic brain injuries and related conditions. Established in 2020, Mind Cure Health Inc. maintains its headquarters in Vancouver, Canada.

Market snapshot

Symbol
MCUR.CN
Price
$0.08
Day change
0.00%
Market cap
$122.5M
P/E ratio
-4.77x
52-week range
0.05-0.09
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Asep Medical Holdings Inc (ASEP.CN)
  • Awakn Life Sciences Corp. (AWKN.NE)
  • Clearmind Medicine Inc. (CMND.CN)
  • Core One Labs Inc. (COOL.CN)
  • Lynx Global Digital Finance Corporation (LYNX.CN)
  • PharmaCielo Ltd. (PCLO.V)
  • Sproutly Canada Inc. (SPR.CN)
  • StateHouse Holdings Inc. (STHZ.CN)

Open Mind Cure Health Inc. (MCUR.CN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.